Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.525 USD | +4.50% | -0.02% | -3.94% |
22/03 | Sangamo Therapeutics Prices $24 Million Registered Direct Offering | MT |
14/03 | Sangamo Therapeutics Pushes Neurology Programs Toward Clinical Development, Wedbush Says | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.94% | 104M | |
+3.05% | 108B | |
+10.37% | 105B | |
+1.57% | 23.46B | |
-12.63% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-7.17% | 17.19B | |
+6.34% | 13.99B | |
+38.21% | 12.53B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Transcript : Sangamo Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024